ZetrOZ, Inc. is pleased to announce that sam® Professional System, its bio-electronic device, has been awarded the Bronze Medal in the Rehabilitation and Assistive Technology Products Category of the 18th Annual Medical Design Excellence Awards competition. Winners, selected from a group of 45 finalists in 10 medical technology product categories, were announced at the 2015 MDEA Ceremony in conjunction with the MD&M East event held on June 9th at the Jacob K. Javits Convention Center in New York.
sam® Professional System delivers sustained acoustic medicine for the treatment of select medical conditions such as the relief of pain, the relief of muscle spasm, the treatment of joint contracture and to increase local blood circulation. It received FDA clearance in the U.S. for up to four hours of continuous daily therapeutic intervention under the FDA’s new wearable ultrasound product category (PFW). sam® also has received the CE Mark and Canada License, and is a Class II medical device in Singapore and Malaysia. In the non-U.S. markets, it is also indicated for healing.
sam® addresses the growing demand for non-pharmaceutical and bio-regenerative alternatives to pharma-based pain treatments in the approximately $62 billion U.S. pain management market. It is used by a wide range of individuals who work in labor-intensive jobs, including professional athletes, looking to more effectively manage chronic pain and improve recovery of overuse injuries such as tendinopathies and muscle strains.
“Recognition by the MDEA will help drive greater awareness of sam® and the important role that sustained acoustic medicine can play in the management of chronic pain,” said George K. Lewis, Jr., Ph.D., co-founder and chief science & technology officer. “Millions of pain sufferers around the world are looking for drug-free alternatives to ease their pain and may benefit from the effectiveness and convenience offered by sam®.”
About ZetrOZ, Inc.
ZetrOZ, Inc. develops wearable bio-electronic devices for the delivery of sustained acoustic medicine. Built on a proprietary miniaturized ultrasound platform designed for the treatment of acute and chronic musculoskeletal conditions, ZetrOZ, Inc. devices are clinically proven to enhance tissue recovery, accelerate the body’s natural healing processes, and relieve pain. Since the company’s founding in 2009, ZetrOZ, Inc. has successfully applied this innovative technology to the development of two products now available on the market: sam® Professional System and UltrOZ™ Elite for the maintenance and rehabilitation of equine athletes. For more information, visit www.zetroz.com.
About the Medical Design Excellence Awards
The Medical Design Excellence Awards are presented by UBM Canon, the global advanced manufacturing and medtech authority, and by Medical Device and Diagnostic Industry (MD+DI), the industry’s central source for late breaking news, information, and business intelligence. MDEA entries are judged by an impartial panel of medtech experts comprised of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts. MDEA jurors review entries based on the following criteria: the ability to overcome all challenges so the product meets its clinical objectives; innovative use of materials, components, and processes; user-related functions improving healthcare delivery and changing traditional medical attitudes or practices; features providing enhanced benefits to the patient in relation to clinical efficacy; manufacturing cost-effectiveness and profitability; and healthcare system benefits. The 2015 Medical Design Excellence Awards are sponsored by: K-Tube Technologies; Medical Packaging Community; Phillips-Medisize; Proto Labs; Stellar Technologies; and Teleflex Medical OEM. Visit www.MDEAwards.com for more info.
Account Executive, Crenshaw Communications